Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients

Journal of Clinical Virology

Volumn 14, Issue 3, 1999, Pages 153-165

  Schirm, Jurjen ^a   Kooistra, André ^a   Van Son, Willem J ^b   Van Der Bij, Wim ^b   Verschuuren, Erik ^b   G Sprenger, Herman ^b   Limburg, Pieter C ^b   Hauw The, T ^b  

^a Public Health Service of Groningen   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

CMV DNA; CMV pp65 test; Hybrid capture test

Indexed keywords

GANCICLOVIR; VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; HYBRIDIZATION; IMMUNE DEFICIENCY; LEUKOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REPRODUCIBILITY; VIRUS DETECTION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GANCICLOVIR; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; MIDDLE AGED; PHOSPHOPROTEINS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; VIRAL MATRIX PROTEINS;

EID: 0032750196     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(99)00063-3     Document Type: Article

References (39)

1. Baldanti F., Zavattoni M., Sarasini A., Gatti M., Chezzi L., Gerna G. Comparative quantification of human cytomegalovirus DNA in blood of immunocompromised patients by PCR and Murex Hybrid CaptureTM system. Clin. Diagn. Virol. 8:1997;159-165.
2. Baldanti F., Revello M.G., Percivalle E., Gerna G. Use of the human cytomegalovirus (HCMV) antigenemia assay for diagnosis and monitoring of HCMV infections and detection of antiviral drug resistance in the immunocompromised. J. Clin. Virol. 11:1998;51-60.
3. Barber L., Egan J.J., Lomax J., Yonan N., Deiraniya A.K., Turner A.J., Woodcock A.A., Fox A.J. Comparative study of three PCR assays with antigenaemia and serology for the diagnosis of HCMV infection in thoracic transplant recipients. J. Med. Virol. 49:1996;137-144.
4. Bek B., Boeckh M., Lepenies J., Bieniek B., Arasteh K., Heise W., Depperman K.-M., Bornhöft G., Stöffler-Meilicke M., Schuller I., Höffken G. High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up. J. Clin. Microbiol. 34:1996;457-459.
5. Boeckh M., Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin. Microbiol. Rev. 11:1998;533-554.
6. Boivin G., Handfield J., Toma E., Murray G., Lalonde R., Bergeron M. Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leucocytes and plasma of human immunodeficiency virus-infected subjects. J. Infect. Dis. 177:1998;355-360.
7. Boom R., Sol C.J.A., Salimans M.M.M., Jansen C.L., Wertheim-van Dillen P.M.E., van der Noordaa J. Rapid and simple methods for purification of nucleic acids. J. Clin. Microbiol. 28:1990;495-503.
8. Cheeseman S.H., Rubin R.H., Stewart J.A., Tolkoff-Rubin N.E., Cosimi A.B., Cantell K., Gilbert J., Winkle S., Herrin J.T., Black P.H., Russell P.S., Hirsch M.S. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. New Engl. J. Med. 24:1979;1345-1349.
9. Chernoff D.N., Miner R.C., Hoo B.S., Shen L.-P., Kelso R.J., Jekic-McMullen D., Lalezari J.P., Chou S., Drew W.L., Kolberg J.A. Quantification of cytomegalovirus DNA in peripheral blood leucocytes by a Branched-DNA signal amplification assay. J. Clin. Microbiol. 35:1997;2740-2744.
10. Cope J.U., Hildesheim A., Schiffman M.H., Manos M.M., Lörincz A.T., Burk R.D., Glass A.G., Greer C., Buckland J., Helgesen K., Scott D.R., Sherman M.E., Kurman R.J., Liaw K.-L. Comparison of the Hybrid Capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J. Clin. Microbiol. 35:1997;2262-2265.
11. Cullen A.P., Long C.D., Lörincz A.T. Rapid detection and typing of herpes simplex virus DNA in clinical specimens by the hybrid capture II signal amplification probe test. J. Clin. Microbiol. 35:1997;2275-2278.
12. Delgado R., Lumbreras C., Alba C., Pedraza M.A., Otero J.R., Gomez R., Moreno E., Noriega A.R., Paya C.V. Low predictive value of polymerase chain reaction for diagnosis of cytomegalovirus disease in liver transplant recipients. J. Clin. Microbiol. 30:1992;1876-1878.
13. Falagas ME, Snydman DR, Ruthazer R, Werner BG, Griffith J and the Boston Center for Liver Transplantation CMVIG Study Group. Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Clin Infect Dis 1997;24:824-829.
14. Gerna G., Zipeto D., Parea M., Revello M.G., Silini E., Percivalle E., Zavattoni M., Grossi P., Milanesi G. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J. Infect. Dis. 164:1991;488-498.
15. Gerna G., Revello M.G., Percivalle E., Morini F. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J. Clin. Microbiol. 30:1992a;1232-1237.
16. Gerna G., Zipeto D., Percivalle E., Parca M., Revello M.G., Maccario R., Peri G., Milanesi G. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leucocytes from viremic patients. J. Infect. Dis. 166:1992b;1236-1244.
17. Gerna G., Furione M., Baldanti F., Sarasini A. Comparative quantitation of human cytomegalovirus DNA in blood leucocytes and plasma of transplant and AIDS patients. J. Clin. Microbiol. 32:1994;2709-2717.
18. Gerna G., Percivalle E., Torsellini M., Revello M.G. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leucocytes. J. Clin. Microbiol. 36:1998a;3585-3589.
19. Gerna G., Zavattoni M., Baldanti F., Sarasini A., Chezzi L., Grossi P., Revello M.G. Human cytomegalovirus (HCMV) leukodnaemia correlates more closely with clinical symptoms than antigenemia and viremia in heart and heart-lung transplant recipients with primary HCMV infection. Transplantation. 65:1998b;1378-1385.
20. Gerna G., Zavattoni M., Percivalle E., Grossi P., Torsellini M., Revello M.G. Rising levels of human cytomegalovirus (HCMV) antigenaemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection. J. Clin. Microbiol. 36:1998c;1113-1116.
21. Gleaves C.A., Smith T.F., Shuster E.A., Pearson G. Comparison of standard tube and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens. J. Clin. Microbiol. 21:1985;217-221.
22. Hebart H., Müller C., Löffler J., Jahn G., Einsele H. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. Bone Marrow Transplant. 17:1996;861-868.
23. Jiwa NM. Early detection of human cytomegalovirus infections in transplant recipients. PhD thesis, 1989, University of Leiden, Netherlands.
24. Manez R., Kusne S., Rinaldo C., Aguado J.M., St.George K., Grossi P., Frye B., Fung J.J., Ehrlich G.D. Time to detection of cytomegalovirus (CMV) DNA in blood leucocytes is a predictor for the development of CMV disease in CMV-seronegative recipients of allografts from CMV-seropositive donors following liver transplantation. J. Infect. Dis. 173:1996;1072-1076.
25. Mazzulli T., Wood S., Chua R., Walmsley S. Evaluation of the Digene Hybrid Capture system for detection and quantitation of human Cytomegalovirus viremia in Human immunodeficiency virus-infected patients. J. Clin. Microbiol. 34:1996;2959-2962.
26. Meyer-König U., Serr A., von Laer D., Kirste G., Wolff C., Haller O., Neumann-Haefelin D., Hufert F.T. Human cytomegalovirus immediate early and late transcripts in peripheral blood leucocytes: diagnostic value in renal transplant recipients. J. Infect. Dis. 171:1995;705-709.
27. Patel R., Smith T.F., Espy M., Pertela D., Wiesner R.H., Krom R.A.F., Paya C.V. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J. Infect. Dis. 171:1995;1010-1014.
28. Reynes J., Montes B., Atoui N., Segondy M. Significance of cytomegalovirus (CMV)-pp65 antigenaemia in the diagnosis of CMV disease in human immunodefiency virus-infected patients. J. Med. Virol. 49:1996;195-198.
29. Rollag H., Sagedal S., Holter E., Degré M., Ariansen S., Nordal K.P. Diagnosis of cytomegalovirus infection in kidney transplant recipients by quantitative RNA-DNA hybrid capture assay for cytomegalovirus DNA in leucocytes. Eur. J. Clin. Microbiol. Infect. Dis. 17:1998;124-127.
30. Schäfer P., Tenschert W., Cremaschi L., Gutensohn K., Laufs R. Utility of major leukocyte subpopulations for monitoring secondary cytomegalovirus infections in renal-allograft recipients by PCR. J. Clin. Microbiol. 36:1998;1008-1014.
31. Schirm J., Timmerije W., van der Bij W., The T.H., Wilterdink J.B., Tegzess A.M., van Son W.J., Schröder F.P. Rapid detection of infectious cytomegalovirus in blood with the aid of monoclonal antibodies. J. Med. Virol. 23:1987;31-40.
32. Storch G.A., Buller R.S., Bailey T.C., Ettinger N.A., Langlois T., Gaudreault-Keener M., Welby P.L. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for the detection of cytomegalovirus in blood leucocytes from solid-organ transplant recipients. J. Clin. Microbiol. 32:1994;997-1003.
33. The T.H., van der Ploeg M., van den Berg A.P., Vlieger A.M., van der Giessen M., van Son W.J. Direct detection of cytomegalovirus in peripheral blood leucocytes-a review of the antigenemia assay and polymerase chain reaction. Transplantation. 54:1992;193-198.
34. The T.H., van den Berg A.P., van Son W.J., Klompmaker I.J., Harmsen M.C., van der Giessen M., Slooff M.J.H. Monitoring for cytomegalovirus after organ transplantation: a clinical perspective. Transpl. Proc. 25:1993;5-9.
35. The T.H., van den Berg A.P., Harmsen M.C., van der Bij W., van Son W.J. The cytomegalovirus antigenemia assay: a plea for standardization. Scan. J. Infect. Dis. Suppl. 99:1995;25-29.
36. van der Bij W., Torensma R., van Son W.J., Anema J., Schirm J., Tegzess A.M.C., The T.H. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J. Med. Virol. 25:1988a;179-188.
37. van der Bij W., Schirm J., Torensma R., van Son W.J., Tegzess A.M.C., The T.H. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J. Clin. Microbiol. 26:1988b;2531-2535.
38. van der Giessen M., van den Berg A.P., van der Bij W., Postma S., van Son W.J., The T.H. Quantitative measurement of CMV-specific IgG and IgM antibodies in relation to CMV antigenemia and disease activity in kidney recipients with an active CMV infection. Clin. Exp. Immun. 80:1990;56-61.
39. Velzing J., Rothbarth P.H., Kroes A.C.M., Quint W.G.V. Detection of cytomegalovirus mRNA and DNA encoding the immediate early gene in peripheral blood leucocytes from immunocompromised patients. J. Med. Virol. 42:1994;164-169.